Authors


Brian P. Mulherin, MD

Latest:

Closing Thoughts on Iron Deficiency Anemia

Panelists discuss how the successful management of iron deficiency anemia requires a comprehensive approach combining early detection, appropriate choice of iron formulation, careful monitoring of treatment response, and addressing barriers to care while emphasizing the importance of patient education and health care system support in achieving optimal outcomes.


Chiao-Li Chan, MSW

Latest:

Evaluating Alternative Methods of Comparing Antihypertensive Treatment Intensity

Medication dose captures modification of hypertension treatment intensity more precisely than medication count, and this measure should be preferred in studies that aim to improve hypertension management.


Chau Truong, MPH

Latest:

Evaluation of a Collaborative Model Between Managed Care and Affordable Housing on Acute Care Costs

A collaborative service model between a managed care organization and an affordable housing provider reduced acute care use and costs.


Dolly Sharma, PhD

Latest:

Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast Cancer

Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.


Amiee Kang, MPH

Latest:

Journey to Anticoagulant Access Following Payer Rejection of Apixaban

Formulary restrictions can create treatment barriers for patients with atrial fibrillation, including unnecessary delays in treatment and prescription abandonment, with vulnerable populations at greater risk.


Jai Seth, MSc

Latest:

Leveraging Patient Activation to Improve Kidney Health in High-Risk Patients

Frequency of patient-provider conversations and patient activation are the 2 most significant predictors of a high-risk patient’s behaviors to prevent kidney disease.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo